Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075333
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075333
Neuroplasticity Market, By Product Type, By Application, By End User, By Geography
PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Neuroplasticity Market is estimated to be valued at USD 14.28 Bn in 2026 and is expected to reach USD 79.49 Bn by 2033, growing at a compound annual growth rate (CAGR) of 27.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 14.28 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 27.80% | 2033 Value Projection: | USD 79.49 Bn |
Neuroplasticity encompasses various interventions, such as neurofeedback systems, brain stimulation devices, cognitive training programs, and other therapies designed to optimize brain function and promote neuroplastic changes.
Market Dynamics:
The increasing prevalence of neurological disorders and growing demand for non-invasive brain stimulation techniques are major factors expected to drive growth of the global neuroplasticity market during the forecast period.
However, lack of awareness, limited research and development, and high costs are expected to hamper the growth of the neuroplasticity market over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global neuroplasticity market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, SharpBrains, Emotiv Inc., BrainCo, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global neuroplasticity market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroplasticity market
Detailed Segmentation:
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Software-Based Solutions
- Hardware-Based Solutions
- By Application (Revenue, USD Bn, 2021 - 2033)
- Stroke Rehabilitation
- Traumatic Brain Injury (TBI) Rehabilitation
- Neurodegenerative Disorders
- Learning and Memory Enhancement
- Mental Health Disorders
- By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Research Institutes and Academic Centers
- Pharmaceutical and Biotechnology Companies
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- NeuroSky Inc.
- Posit Science Corporation
- BrainHQ
- Synaptitude Brain Health
- Mindmaze SA
- NeuroVigil Inc.
- Lumosity
- Neuronetics, Inc.
- CogniFit
- BrainHQ
- SharpBrains
- Emotiv Inc.
- BrainCo
- Neuroscape
- Neuroplast BV
- Reha Technology AG
- Virtualware Group
- Nexeon Medsystems Inc.
Product Code: CMI6032
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Global Neuroplasticity, By Product Type
- Market Global Neuroplasticity, By Application
- Market Global Neuroplasticity, By End User
- Market Global Neuroplasticity, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of neurological disorders
- Increasing research and development activities
- Technological advancements
- Growing demand for non-invasive and personalized treatments
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Neuroplasticity Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Software-Based Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Hardware-Based Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Neuroplasticity Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Stroke Rehabilitation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Traumatic Brain Injury (TBI) Rehabilitation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Neurodegenerative Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Learning and Memory Enhancement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Mental Health Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Neuroplasticity Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Neuroplasticity Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- NeuroSky Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Posit Science Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BrainHQ
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Synaptitude Brain Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindmaze SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NeuroVigil Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lumosity
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neuronetics, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CogniFit
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SharpBrains
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emotiv Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BrainCo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neuroscape
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neuroplast BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reha Technology AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virtualware Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nexeon Medsystems Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.